Afuco™ Anti-NGCGM3 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-H58) (CAT#: AFC-TAB-H58)
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant Mouse antibody to Human NGcGM3. It is a therapeutic cancer vaccine for the treatment of solid tumors. It induces the patient's immune system to generate a response against a cancer-specific molecular target with the purpose of blocking tumor growth, slowing disease progression and ultimately increasing patient survival.
We specialize in custom recombinant antibody production, offering seamless execution from provided sequences to high-quality antibody deliverables, ensuring optimal yield and purity.
Specifications
- Host Species
- Mouse
- Derivation
- Mouse
- Type
- ADCC enhanced antibody
- Specificity
- idiotope of anti-(N-glycolylneuraminic acid (NeuGc, NGNA) -gangliosides GM3) Mus musculus IgM-kappa monoclonal antibody P3 [Homo sapiens]
- Species Reactivity
- Human
- Applications
- FC, IP, ELISA, Neut, FuncS, IF
- Conjugate
- Unconjugated
- Trade name
- Vaxira
- Generic Name
- Racotumomab
- Related Disease
- Breast cancers
Product Property
- Purity
- >95% by SDS-PAGE
- Storage
- Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Target
- Alternative Names
- N-glycolil (NGc) GM3; NGcGM3; NGNA ganglioside
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "racotumomab"
Anti-Human NGcGM3 Recombinant Antibody (Racotumomab)Recombinant Mouse antibody to Human NGcGM3. Racotumomab (trade name Vaxira) is a therapeutic cancer vaccine for the treatment of solid tumors. It induces the patient's immune system to generate a response against a cancer-specific molecular target with the purpose of blocking tumor growth, slowing disease progression and ultimately increasing patient survival.
DrugMonitor™ Anti-Racotumomab Antibody (VS-1224-YC972)Racotumomab is a form of active immunotherapy designed to stimulate the immune system to recognize and combat cancer cells. It has been used in trials for treating glioma, Wilms' tumor, neuroblastoma, retinoblastoma, and Ewing's sarcoma. The DrugMonitor™ Anti-Racotumomab Antibody (VS-1224-YC972) is an anti-drug antibody (ADA) against Racotumomab. This drug-based antibody is raised in mice immunized with the Racotumomab. The anti-Racotumomab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Racotumomab in samples.
See other products for "NGcGM3"
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-H58 | Anti-Human NGcGM3 Recombinant Antibody (Racotumomab) | Inhib, Agonist, Cyt, ELISA | IgG1 - kappa |
Customer Reviews and Q&As
There are currently no Customer reviews or questions for AFC-TAB-H58. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: ELISA, Neut, IF, IP, FC, FuncS
Application: Neut, ELISA, IF, IP, FuncS, FC, ICC
Application: IP, IF, FuncS, FC, Neut, ELISA, IHC
Application: WB, ELISA, IHC, IP, SPR, FuncS
Application: FC, IA, IF, IP, IHC, FuncS
Application: ELISA
Application: WB, IHC-Fr, IHC-P, ICC, IF
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.